These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 16787410

  • 1. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J, Ittner LM, Kins S.
    J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
    [Abstract] [Full Text] [Related]

  • 2. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA.
    Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
    [Abstract] [Full Text] [Related]

  • 3. Age-dependent axonal degeneration in an Alzheimer mouse model.
    Wirths O, Weis J, Kayed R, Saido TC, Bayer TA.
    Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P.
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [Abstract] [Full Text] [Related]

  • 5. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 6. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q, Zhang X, Sun A.
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Experimental models in Alzheimer's disease].
    Manzano S, González J, Marcos A, Payno M, Villanueva C, Matías-Guiu J.
    Neurologia; 2009 May; 24(4):255-62. PubMed ID: 19603296
    [Abstract] [Full Text] [Related]

  • 9. Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity.
    Rusu P, Jansen A, Soba P, Kirsch J, Löwer A, Merdes G, Kuan YH, Jung A, Beyreuther K, Kjaerulff O, Kins S.
    Eur J Neurosci; 2007 Feb; 25(4):1079-86. PubMed ID: 17331204
    [Abstract] [Full Text] [Related]

  • 10. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
    Brendza RP, O'Brien C, Simmons K, McKeel DW, Bales KR, Paul SM, Olney JW, Sanes JR, Holtzman DM.
    J Comp Neurol; 2003 Feb 17; 456(4):375-83. PubMed ID: 12532409
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E, Shoji M, Kawarabayashi T, Sasaki A, Matsubara E, Murakami T, Wuhua X, Tamura S, Ikeda M, Ishiguro K, Saido TC, Westaway D, St George Hyslop P, Harigaya Y, Abe K.
    Brain Res; 2006 Jun 13; 1094(1):192-9. PubMed ID: 16713590
    [Abstract] [Full Text] [Related]

  • 13. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J, Levy M, Dickson DW, Potter H.
    Brain; 2006 Nov 13; 129(Pt 11):3020-34. PubMed ID: 16987932
    [Abstract] [Full Text] [Related]

  • 14. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain.
    Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF.
    Brain Res; 2004 Jun 25; 1012(1-2):29-41. PubMed ID: 15158158
    [Abstract] [Full Text] [Related]

  • 15. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM, Pérez M, Puig B, Gich I, Lim F, Cuadrado M, Sesma T, Catena S, Sánchez B, Nieto M, Gómez-Ramos P, Morán MA, Cabodevilla F, Samaranch L, Ortiz L, Pérez A, Ferrer I, Avila J, Gómez-Isla T.
    Neurobiol Dis; 2005 Dec 25; 20(3):814-22. PubMed ID: 16125396
    [Abstract] [Full Text] [Related]

  • 16. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 25; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 17. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M.
    Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725
    [Abstract] [Full Text] [Related]

  • 18. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice.
    Eckert A, Hauptmann S, Scherping I, Rhein V, Müller-Spahn F, Götz J, Müller WE.
    Neurodegener Dis; 2008 Jan 15; 5(3-4):157-9. PubMed ID: 18322377
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC, Ittner LM, Gehrig P, Nergenau D, Shepherd C, Halliday G, Götz J.
    Proteomics; 2006 Dec 15; 6(24):6566-77. PubMed ID: 17111439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.